BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29962241)

  • 1. Effect of coverage gap on healthcare utilization among Medicare beneficiaries with chronic obstructive pulmonary disorder.
    Sansgiry SS; Bhansali A; Serna O; Kamdar M; Fleming M; Abughosh S; Stanford RH
    Curr Med Res Opin; 2019 Feb; 35(2):321-328. PubMed ID: 29962241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Associated with Entering the Prescription Drug Coverage Gap Among Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease.
    Xu Q; Laxa SS; Serna O; Sansgiry SS
    Popul Health Manag; 2021 Apr; 24(2):241-248. PubMed ID: 32343925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital and emergency department utilization associated with treatment for chronic obstructive pulmonary disease in a managed-care Medicare population.
    Simoni-Wastila L; Yang HW; Blanchette CM; Zhao L; Qian J; Dalal AA
    Curr Med Res Opin; 2009 Nov; 25(11):2729-35. PubMed ID: 19778165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare utilization and costs associated with COPD among SEER-Medicare beneficiaries with NSCLC.
    Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
    J Med Econ; 2018 Sep; 21(9):861-868. PubMed ID: 29857784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health Costs and Outcomes Associated with Medicare Part D Prescription Drug Cost-Sharing in Beneficiaries on Dialysis.
    Park H; Rascati KL; Lawson KA; Barner JC; Richards KM; Malone DC
    J Manag Care Spec Pharm; 2015 Oct; 21(10):956-64. PubMed ID: 26402394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Nebulized Arformoterol Treatment: A Retrospective Analysis of Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease.
    Gilmer TP; Celli BR; Xu Z; Cho-Reyes S; Dembek C; Navaie M
    COPD; 2019 Apr; 16(2):140-151. PubMed ID: 31215259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of PAP therapy on hospitalization rates in Medicare beneficiaries with COPD and coexisting OSA.
    Singh G; Agarwal A; Zhang W; Kuo YF; Sultana R; Sharma G
    Sleep Breath; 2019 Mar; 23(1):193-200. PubMed ID: 29931497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Participation in Pulmonary Rehabilitation after Hospitalization for Chronic Obstructive Pulmonary Disease among Medicare Beneficiaries.
    Spitzer KA; Stefan MS; Priya A; Pack QR; Pekow PS; Lagu T; Pinto-Plata VM; ZuWallack RL; Lindenauer PK
    Ann Am Thorac Soc; 2019 Jan; 16(1):99-106. PubMed ID: 30417670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin use and health care utilization in patients with coexisting chronic obstructive pulmonary disease and diabetes mellitus.
    Bishwakarma R; Zhang W; Lin YL; Kuo YF; Cardenas VJ; Sharma G
    Int J Chron Obstruct Pulmon Dis; 2018; 13():793-800. PubMed ID: 29551895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival associated with chronic obstructive pulmonary disease among SEER-Medicare beneficiaries with non-small-cell lung cancer.
    Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
    Int J Chron Obstruct Pulmon Dis; 2019; 14():893-903. PubMed ID: 31118599
    [No Abstract]   [Full Text] [Related]  

  • 13. Healthcare utilization, medical costs and mortality associated with malnutrition in patients with chronic obstructive pulmonary disease: a matched cohort study.
    Jerng JS; Tang CH; Cheng RW; Wang MY; Hung KY
    Curr Med Res Opin; 2019 Jul; 35(7):1265-1273. PubMed ID: 30676096
    [No Abstract]   [Full Text] [Related]  

  • 14. Participation in Pulmonary Rehabilitation by Veterans Health Administration and Medicare Beneficiaries After Hospitalization for Chronic Obstructive Pulmonary Disease.
    Vercammen-Grandjean C; Schopfer DW; Zhang N; Whooley MA
    J Cardiopulm Rehabil Prev; 2018 Nov; 38(6):406-410. PubMed ID: 30252780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen.
    Rascati KL; Akazawa M; Johnsrud M; Stanford RH; Blanchette CM
    Clin Ther; 2007 Jun; 29(6):1203-13. PubMed ID: 17692734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population.
    Menzin J; Boulanger L; Marton J; Guadagno L; Dastani H; Dirani R; Phillips A; Shah H
    Respir Med; 2008 Sep; 102(9):1248-56. PubMed ID: 18620852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of health care services among Medicare beneficiaries who visit federally qualified health centers.
    Lavelle TA; Rose AJ; Timbie JW; Setodji CM; Wensky SG; Giuriceo KD; Friedberg MW; Malsberger R; Kahn KL
    BMC Health Serv Res; 2018 Jan; 18(1):41. PubMed ID: 29370837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and economic burden of COPD in a medicaid population.
    D'Souza AO; Shah M; Dhamane AD; Dalal AA
    COPD; 2014 Apr; 11(2):212-20. PubMed ID: 24111752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal trends in healthcare utilization following primary melanoma diagnosis among Medicare beneficiaries.
    Lott JP; Wang Q; Titus LJ; Onega T; Nelson HD; Weinstock MA; Elmore JG; Tosteson ANA
    Br J Dermatol; 2017 Sep; 177(3):845-853. PubMed ID: 28369774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence and healthcare utilization among older adults with COPD and depression.
    Albrecht JS; Khokhar B; Huang TY; Wei YJ; Harris I; Moyo P; Hur P; Lehmann SW; Netzer G; Simoni-Wastila L
    Respir Med; 2017 Aug; 129():53-58. PubMed ID: 28732836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.